Atlas Trials

Receipt of Cal-1 Modified Hematopoietic Cellular Products

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Receipt of Cal-1 Modified Hematopoietic Cellular Products

RecordFirmDate
Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients (NCT02390297)Calimmune, Inc.2015-04-01

Track Receipt of Cal-1 Modified Hematopoietic Cellular Products automatically

Every clearance here is in the API, with alerts when new ones post.